T. Rowe Price Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.2M | Sell |
49,917
-1,892,828
| -97% | -$767M | 0.01% | 499 |
|
|
2025
Q1 | $967M | Sell |
1,942,745
-1,141,155
| -37% | -$568M | 0.64% | 32 |
|
|
2024
Q4 | $1.6B | Buy |
3,083,900
+1,433,444
| +87% | +$746M | 0.99% | 16 |
|
|
2024
Q3 | $1.02B | Buy |
1,650,456
+320,020
| +24% | +$198M | 0.62% | 42 |
|
|
2024
Q2 | $736M | Buy |
1,330,436
+501,370
| +60% | +$277M | 0.46% | 65 |
|
|
2024
Q1 | $482M | Buy |
829,066
+823,295
| +14,266% | +$479M | 0.29% | 94 |
|
|
2023
Q4 | $3.06M | Sell |
5,771
-2,178,776
| -100% | -$1.16B | ﹤0.01% | 538 |
|
|
2023
Q3 | $1.11B | Buy |
2,184,547
+306,392
| +16% | +$155M | 0.78% | 33 |
|
|
2023
Q2 | $980M | Sell |
1,878,155
-507,729
| -21% | -$265M | 0.67% | 35 |
|
|
2023
Q1 | $1.38B | Sell |
2,385,884
-51,400
| -2% | -$29.6M | 0.99% | 20 |
|
|
2022
Q4 | $1.34B | Sell |
2,437,284
-749,436
| -24% | -$413M | 1.03% | 19 |
|
|
2022
Q3 | $1.62B | Buy |
+3,186,720
| New | +$1.62B | 1.29% | 11 |
|